XML 70 R38.htm IDEA: XBRL DOCUMENT v3.8.0.1
Share-Based Payments (Tables)
 9 Months Ended
Sep. 30, 2017
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Share-based compensation expense included in condensed consolidated statements of income
The following table summarizes share-based compensation expense included in our condensed consolidated statements of income:
 
For the Three Months
Ended September 30,
 
For the Nine Months
Ended September 30,
(In millions)
2017
 
2016
 
2017
 
2016
Research and development
$
19.5

 
$
22.7

 
$
55.7

 
$
65.6

Selling, general and administrative
23.6

 
31.2

 
71.9

 
94.6

Restructuring charges
—

 
—

 
—

 
(1.8
)
Subtotal
43.1

 
53.9

 
127.6

 
158.4

Capitalized share-based compensation costs
(2.5
)
 
(3.2
)
 
(7.6
)
 
(10.7
)
Share-based compensation expense included in total cost and expenses
40.6

 
50.7

 
120.0

 
147.7

Income tax effect
(10.9
)
 
(14.6
)
 
(31.8
)
 
(42.5
)
Share-based compensation expense included in net income attributable to Biogen Inc.
$
29.7

 
$
36.1

 
$
88.2

 
$
105.2
Summary of share-based compensation expense associated with each of our share-based compensating programs
The following table summarizes share-based compensation expense associated with each of our share-based compensation programs:
 
For the Three Months
Ended September 30,
 
For the Nine Months
Ended September 30,
(In millions)
2017
 
2016
 
2017
 
2016
Market stock units
$
4.5

 
$
5.7

 
$
17.1

 
$
27.0

Time-vested restricted stock units
26.7

 
28.5

 
81.2

 
92.5

Cash settled performance units
7.0

 
7.9

 
13.0

 
12.7

Performance units
3.2

 
9.1

 
8.9

 
17.3

Employee stock purchase plan
1.7

 
2.7

 
7.4

 
8.9

Subtotal
43.1

 
53.9

 
127.6

 
158.4

Capitalized share-based compensation costs
(2.5
)
 
(3.2
)
 
(7.6
)
 
(10.7
)
Share-based compensation expense included in total cost and expenses
$
40.6

 
$
50.7

 
$
120.0

 
$
147.7